When a doctor makes a clinical decision—whether diagnosing diabetes, monitoring kidney function, or planning cancer therapy—the accuracy of the laboratory report is paramount. NABL Accreditation (MC-6849) under ISO 15189:2022 is the benchmark for medical laboratory competence.
At QXL Diagnostics, quality assurance encompasses three critical phases:
- Pre-Analytical: Temperature-controlled sample transport, barcoded primary tube validation, and standardized sample preparation.
- Analytical: Daily Internal Quality Control (IQC) using multi-level controls, regular calibration, and participation in External Quality Assessment Schemes (EQAS).
- Post-Analytical: Multi-layer result verification and clinical sign-off by senior consultant doctors (MD Pathologists, Biochemists, Microbiologists).
This rigorous framework ensures that every report delivered to patients and doctors meets international scientific standards.
Medical & Laboratory Disclaimer
This clinical article is published solely for patient education and informational purposes. It does not replace personal medical advice, clinical diagnosis, prenatal genetic counselling, or obstetric supervision. Appropriate laboratory investigations must be determined by your treating physician based on your personal health history.
Dr. Shantakumar Muruda, MD (Biochemistry)
Head of Clinical Biochemistry & Quality Management, QXL Diagnostics Bengaluru (NABL Accredited Laboratory MC-6849). Trained Lead Assessor for ISO 15189:2022 medical laboratory standards.
QXL Clinical Editorial Commitment: Every health guide, biomarker explanation, and screening schedule published on this portal undergoes rigorous clinical review by qualified MD pathologists and biochemists to ensure adherence to peer-reviewed evidence (ACOG, WHO, ICMR) and laboratory diagnostic accuracy.
